methylprednisolone has been researched along with Gasser Syndrome in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (7.69) | 18.7374 |
1990's | 5 (19.23) | 18.2507 |
2000's | 8 (30.77) | 29.6817 |
2010's | 10 (38.46) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Bresin, E; Carbone, V; Chironna, M; Conti, P; Gagliardi, D; Giordano, M; Lasorella, ML; Losito, L; Milella, L; Netti, GS; Piscopo, G; Ranieri, E; Santangelo, L; Spadaccino, F; Torres, DD; Trabacca, A | 1 |
Clay, T; Das, A; Dean, A | 1 |
Fukushima, T; Iwasawa, T; Makino, K; Nakamura, G; Nanasawa, S; Suzuki, Y | 1 |
Boxer, M; Lien, YH | 1 |
Burns, A; Gandhi, V; Goodship, T | 1 |
Ishida, Y; Misaki, T; Miyawaki, T; Mizuguchi, M; Okabe, N; Okumura, A; Sata, T; Takanashi, J; Taneichi, H; Yahata, Y | 1 |
Antonijević, NM; Bettoni, G; Budisin, Z; Casoli, G; Jevtić, D; Miković, D; Obradović, S; Peyvandi, F; Rajić, Z; Savić, N; Vuclić, D | 1 |
Irifuku, T; Masaki, T; Naito, T; Ogawa, T | 1 |
Altintas, A; Ansari, B; Naser Moghadasi, A; Okhovat, AA; Rezaali, S | 1 |
Camp-Sorrell, D | 1 |
Avcin, T; Benedik-Dolnicar, M; Grosek, S; Meglic, A | 1 |
Ito, E; Nakahata, T; Oki, E; Shinagawa, T; Suzuki, K; Tanaka, H; Tsugawa, K; Tsuruga, K | 1 |
Katzenstein, HM; Warshaw, B; Watt, T | 1 |
Fujita, H; Ito, E; Oki, E; Shinagawa, T; Tanaka, H; Tsuruga, K; Yashiro, T | 1 |
Audia, S; Berthier, S; Bonnotte, B; Janikashvili, N; Leguy, V; Lorcerie, B; Martin, L; Samson, M | 1 |
Fujigaki, Y; Hishida, A; Isozaki, T; Ohashi, N; Sugiura, T; Togawa, A; Yamamoto, T; Yonemura, K | 1 |
Anacleto, FE; Cifra, CL; Elises, JS | 1 |
Bell, WR; Ridolfi, RL | 1 |
Güçlü, A; Irken, G; Kavukçu, S; Olgun, N | 1 |
Bren, AF; Buturovic, J; Ferluga, D; Kandus, A; Kaplan Pavlovcic, S; Koselj, M; Kovac, D; Lindic, J; Ponikvar, R; Vizjak, A | 1 |
Kaynar, K; Mocan, H; Mocan, MZ | 1 |
Hasegawa, T; Hino, M; Kono, K; Nakamae, H; Nishiki, S; Ohta, K; Okura, H; Takubo, T; Tatsumi, N; Yamane, T | 1 |
Ihara, T; Kakisita, E; Minami, N; Mori, Y; Omine, M; Shiku, H; Tamaki, S; Wada, H | 1 |
Hsueh, S; Huang, JL; Tsao, CH | 1 |
Fujimura, Y; Gabazza, EC; Ishizashi, H; Matsumoto, M; Minami, N; Mori, Y; Nobori, T; Shiku, H; Wada, H; Yagi, H | 1 |
Gerdes, H; Goebel, KM; von Manteuffel, G; Zehner, J | 1 |
2 review(s) available for methylprednisolone and Gasser Syndrome
Article | Year |
---|---|
Hemolytic uremic syndrome.
Topics: Adult; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antihypertensive Agents; Anus Neoplasms; Blood Component Transfusion; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnosis, Differential; Drug Monitoring; Female; Hemolytic-Uremic Syndrome; Humans; Methylprednisolone; Mitomycin; Nurse's Role; Nursing Assessment; Oncology Nursing; Plasma; Plasmapheresis; Rare Diseases; Renal Dialysis; Splenectomy | 2008 |
Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Child; Diagnosis, Differential; Female; Hemolytic-Uremic Syndrome; Humans; Kidney Diseases; Male; Methylprednisolone; Middle Aged; Neurologic Manifestations; Plasma Exchange; Prednisone; Purpura, Thrombotic Thrombocytopenic; Syndrome | 1981 |
24 other study(ies) available for methylprednisolone and Gasser Syndrome
Article | Year |
---|---|
Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Escherichia coli Infections; Female; Hemolytic-Uremic Syndrome; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Neurological Rehabilitation; Plasma Exchange; Polyneuropathies; Shiga-Toxigenic Escherichia coli | 2021 |
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Methylprednisolone; Paclitaxel; Pancreatic Neoplasms | 2019 |
[Case report of acute encephalopathy caused by enterohemorrhagic Escherichia coli infection in a 24-year-old woman].
Topics: Acute Disease; Antigens, Tumor-Associated, Carbohydrate; Brain Diseases; Enterohemorrhagic Escherichia coli; Escherichia coli Infections; Female; Hemolytic-Uremic Syndrome; Humans; Methylprednisolone; Plasma Exchange; Prednisolone; Pulse Therapy, Drug; Risk; Shiga Toxin; Treatment Outcome; Trihexosylceramides; Young Adult | 2019 |
Collateral Damages by Magic Bullets: Hemolytic Uremic and Capillary Leak Syndromes After Moxetumomab Pasudotox Therapy.
Topics: Aged; Bacterial Toxins; Capillary Leak Syndrome; Combined Modality Therapy; Exotoxins; Female; Follow-Up Studies; Hemolytic-Uremic Syndrome; Humans; Leukemia, Hairy Cell; Methylprednisolone; Multimorbidity; Platelet Transfusion; Renal Dialysis; Risk Assessment; Treatment Outcome | 2019 |
A complementary component to atypical haemolytic uraemic syndrome.
Topics: Adult; Atypical Hemolytic Uremic Syndrome; Complement System Proteins; Diagnosis, Differential; Hemolytic-Uremic Syndrome; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Mutation; Treatment Outcome; Young Adult | 2013 |
Clinical and radiologic features of encephalopathy during 2011 E coli O111 outbreak in Japan.
Topics: Adult; Child; Disease Outbreaks; Escherichia coli Infections; Female; Hemolytic-Uremic Syndrome; Humans; Japan; Male; Methylprednisolone; Neurotoxicity Syndromes; Pulse Therapy, Drug; Radiography; Retrospective Studies; Shiga-Toxigenic Escherichia coli; Treatment Outcome | 2014 |
Clinical experience in treatment of thrombotic thrombocytopenic purpura--hemolytic uremic syndrome with 28 patients.
Topics: ADAM Proteins; ADAMTS13 Protein; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Autoantibodies; Female; Hemolytic-Uremic Syndrome; Humans; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Plasma; Plasma Exchange; Prednisone; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Young Adult | 2013 |
Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Female; Glomerulonephritis; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Lysosomal-Associated Membrane Protein 2; Methylprednisolone; Plasma Exchange; Prednisolone; Proteinuria; Pulse Therapy, Drug; Treatment Outcome | 2014 |
Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report.
Topics: Adult; Anti-Inflammatory Agents; Female; Hemolytic-Uremic Syndrome; Humans; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Purpura, Thrombotic Thrombocytopenic; Spinal Cord | 2017 |
Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome.
Topics: ADAM Proteins; ADAMTS13 Protein; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Child, Preschool; Complement Factor H; Drug Therapy, Combination; Fingers; gamma-Globulins; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Immunologic Factors; Male; Methylprednisolone; Microcirculation; Peripheral Vascular Diseases; Plasmapheresis | 2008 |
Alternative treatment for systemic involvement in a child with postdiarrheal hemolytic-uremic syndrome.
Topics: Child; Combined Modality Therapy; Cytokines; Diarrhea; Glucocorticoids; Hemodiafiltration; Hemolytic-Uremic Syndrome; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone | 2008 |
Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin.
Topics: Blood Transfusion; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Male; Membrane Cofactor Protein; Methylprednisolone; Mutation; Treatment Outcome | 2009 |
Anti-inflammatory treatment for post-diarrhoeal haemolytic–uraemic syndrome with central nervous system involvement.
Topics: Anti-Inflammatory Agents; Central Nervous System Diseases; Child, Preschool; Consciousness Disorders; Diarrhea; Escherichia coli; Female; Hemolytic-Uremic Syndrome; Humans; Immunoglobulins, Intravenous; Inflammation Mediators; Magnetic Resonance Imaging; Methylprednisolone; Pulse Therapy, Drug; Seizures; Treatment Outcome | 2010 |
Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange.
Topics: Acute Kidney Injury; Adult; Biopsy; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Erythrocytes, Abnormal; Female; Hemolytic-Uremic Syndrome; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Methylprednisolone; Models, Immunological; Mycophenolic Acid; Plasma Exchange; Prednisone | 2012 |
Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hemolysis; Hemolytic-Uremic Syndrome; Humans; Hydroxyurea; Interferon-alpha; Kidney Failure, Chronic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Pulse Therapy, Drug; Renal Dialysis; Thrombocytopenia | 2003 |
Postpartum hemolytic uremic syndrome in a 17-year-old Filipina primigravid.
Topics: Abruptio Placentae; Adolescent; Anti-Inflammatory Agents; Cesarean Section; Erythrocyte Transfusion; Female; Hemolytic-Uremic Syndrome; Humans; Kidney; Methylprednisolone; Plasma; Postpartum Period; Pre-Eclampsia; Prednisone; Pregnancy; Renal Dialysis | 2003 |
Atypical hemolytic uremic syndrome.
Topics: Child; Combined Modality Therapy; Female; Hemolytic-Uremic Syndrome; Humans; Methylprednisolone; Plasma Exchange | 1995 |
Cyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluation.
Topics: Adult; Cadaver; Child; Cyclosporine; Female; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Time Factors; Tissue Donors | 1998 |
Haemolytic-uraemic syndrome following a scorpion sting.
Topics: Adult; Animals; Blood Component Transfusion; Cardiotonic Agents; Dopamine; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Male; Methylprednisolone; Plasma; Scorpion Stings; Scorpions | 1998 |
[Recurrent hemolytic uremic syndrome induced by pranoprofen].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Female; Hemolytic-Uremic Syndrome; Humans; Methylprednisolone; Plasma Exchange; Propionates; Recurrence; Treatment Outcome | 1999 |
Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan.
Topics: Adolescent; Adult; Aged; Aspirin; Bacterial Toxins; Child; Child, Preschool; Clinical Trials as Topic; Disease-Free Survival; Female; Fibrinolytic Agents; Hemolytic-Uremic Syndrome; Heparin; Humans; Infant; Infant, Newborn; Japan; Male; Methylprednisolone; Middle Aged; Mitomycin; Plasma Exchange; Platelet Aggregation Inhibitors; Pregnancy; Purpura, Thrombotic Thrombocytopenic; Recurrence; Renal Dialysis; Shiga Toxin 1; Steroids; Survival Rate; Treatment Outcome | 1999 |
Initial presentation of hemolytic uremic syndrome in a boy with systemic lupus erythematosus.
Topics: Adolescent; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Hemolytic-Uremic Syndrome; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Severity of Illness Index; Treatment Outcome | 2002 |
Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
Topics: ADAM Proteins; ADAMTS13 Protein; Adolescent; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases; Biomarkers; Combined Modality Therapy; Female; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Male; Metalloendopeptidases; Methylprednisolone; Middle Aged; Plasma Exchange; Prognosis; Purpura, Thrombotic Thrombocytopenic; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Failure; von Willebrand Factor | 2002 |
[Glucocorticoid-induced effect of erythropoietin in haemolytic anaemia with uraemia and red cell enzyme deficiency (author's transl)].
Topics: Adult; Anemia, Hemolytic, Congenital Nonspherocytic; Deficiency Diseases; Erythrocytes; Erythropoietin; Female; Hemolytic-Uremic Syndrome; Humans; Male; Methylprednisolone; Pyruvate Kinase | 1978 |